Biotech · Private company
Mesoblast International Sàrl
Track this companyFree. Adds Mesoblast International Sàrl to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ChondrogenPhase 2 · Recovery Following Partial Medial MeniscectomyClinicalTrials.gov · fetched Nov 12, 2026
- HyaluronanPhase 2 · Recovery Following Partial Medial MeniscectomyClinicalTrials.gov · fetched Nov 12, 2026
- Mesenchymal Stem CellsPhase 2 · Recovery Following Partial Medial MeniscectomyClinicalTrials.gov · fetched Nov 12, 2026
- Remestemcel-LModerate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following MeniscectomyPHASE1_PHASE2 · COMPLETED · started Jun 1, 2008ClinicalTrials.gov NCT00702741 · fetched Nov 12, 2026
- A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following MeniscectomyPHASE1_PHASE2 · COMPLETED · started Sep 1, 2005ClinicalTrials.gov NCT00225095 · fetched Nov 12, 2026
- Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 InfectionNO_LONGER_AVAILABLEClinicalTrials.gov NCT04366830 · fetched Nov 12, 2026